Hexadecane

Hexadecane

SCHEMBL4476638

CCCCCCCCCCCCCCCC.OCC(O)CO

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.60
LMNA P02545 6/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 1/20 0.53
KDM4E B2RXH2 2/20 0.52
DUSP3 P51452 1/20 0.52
CYP2D6 P10635 2/20 0.50
SPHK1 Q9NYA1 1/20 0.50
GMNN O75496 1/20 0.50
POLB P06746 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50
BLM P54132 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonane SCHEMBL11639112 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Decane SCHEMBL27510417 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Dodecane SCHEMBL16652552 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Dodecane SCHEMBL4233135 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Octane SCHEMBL2362539 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Heptane SCHEMBL8025180 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Octane SCHEMBL3691269 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Glycerin SCHEMBL28505432 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Octane SCHEMBL2522455 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A
Tetradecane SCHEMBL27410093 1.00 USP2 (0.60) USP2LMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120845-B1 NANOPARTICLES FOR USE IN COSMETIC AND DERMATOLOGICAL FORMULATIONS ROVI COSMETICS INT GMBH (DE) 2012-10-24 EP claimed
CN-109069424-A Liposome bacterin 格里菲斯大学 2018-12-21 CN disclosed
EP-1434562-B1 COSMETIC AND DERMATOLOGICAL STICK BEIERSDORF AG (DE) 2017-08-16 EP disclosed
CN-106606775-A liposomal group A streptococcal vaccine 格里菲斯大学 2017-05-03 CN disclosed
EP-2120845-B1 NANOPARTICLES FOR USE IN COSMETIC AND DERMATOLOGICAL FORMULATIONS ROVI COSMETICS INT GMBH (DE) 2012-10-24 EP disclosed
EP-2120845-A1 NANOPARTICLES FOR USE IN COSMETIC AND DERMATOLOGICAL FORMULATIONS ROVI Cosmetics International GmbH (DE) 2009-11-25 EP disclosed
EP-1993507-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE Engels, Peter (DE) 2008-11-26 EP disclosed
WO-2008101546-A1 NANOPARTICLES FOR USE IN COSMETIC AND DERMATOLOGICAL FORMULATIONS ROVI COSMETICS INTERNATIONAL GMBH (DE) 2008-08-28 WO disclosed
CN-100379756-C Polyamid-oligonucleotide derivative, preparation and application of same HOECHST AG (DE) 2008-04-09 CN disclosed
WO-2007104454-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE ENGELS PETER (DE) 2007-09-20 WO disclosed
EP-0904051-A1 COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A REDUCED FEELING OF STICKINESS Beiersdorf Aktiengesellschaft (DE) 1999-03-31 EP disclosed
EP-0876154-A1 USING SERINE-PROTEASES FOR ACNE AND INFLAMED COMEDONES Beiersdorf Aktiengesellschaft (DE) 1998-11-11 EP disclosed
WO-1997044009-A1 COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A REDUCED FEELING OF STICKINESS BEIERSDORF AG (DE) 1997-11-27 WO disclosed
WO-1997039732-A1 USE OF SALIX NIGRA EXTRACT AS AN ACTIVE ANTI-IRRITATION AGENT IN COSMETIC AND TOPICAL DERMATOLOGICAL PREPARATIONS BEIERSDORF AG (DE) 1997-10-30 WO disclosed
EP-0801946-A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions Beiersdorf Aktiengesellschaft (DE) 1997-10-22 EP disclosed
EP-0801945-A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions Beiersdorf Aktiengesellschaft (DE) 1997-10-22 EP disclosed
WO-1997025059-A1 USING SERINE-PROTEASES FOR ACNE AND INFLAMED COMEDONES BEIERSDORF AG (DE) 1997-07-17 WO disclosed
EP-0769291-A1 Active agent combination against acne and inflamed comedones Beiersdorf Aktiengesellschaft (DE) 1997-04-23 EP disclosed
EP-0687467-A2 Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients Beiersdorf Aktiengesellschaft (DE) 1995-12-20 EP disclosed
CN-1112126-A Polyamid-oligonucleotide derivative, preparation and application of same HOECHST AG (DE) 1995-11-22 CN disclosed